BDBM752397 (S)-2-(2-(11-acetyl-3- methylpyrimido[4'',5'':6,7] cyclohepta[1,2-f]indazol- 9(5H)-yl)-N-methylacet- amido)-N-(6-bromo-3- methylpyridin-2-yl)pro- panamide::US20250197403, Compound 109

SMILES CC(=O)c1nn(CC(=O)N(C)[C@@H](C)C(=O)Nc2nc(Br)ccc2C)c2cc3c(cc12)-c1cnc(C)nc1CC=C3

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 752397   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM752397((S)-2-(2-(11-acetyl-3- methylpyrimido[4',5':6,7] c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
US Patent